Sleep studies and rebound insomnia: methodological problems, laboratory findings, and clinical implications.
D014151:Anti-Anxiety Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D012890:Sleep / Q000187:drug effects / Q000502:physiology; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy* / Q000209:etiology; D013375:Substance Withdrawal Syndrome / Q000150:complications
D014151:Anti-Anxiety Agents; D006993:Hypnotics and Sedatives